Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. / Adamo, Marianna; Chioncel, Ovidiu; Pagnesi, Matteo; Bayes-Genis, Antoni; Abdelhamid, Magdy; Anker, Stefan D.; Antohi, Elena Laura; Badano, Luigi; Ben Gal, Tuvia; Böhm, Michael; Delgado, Victoria; Dreyfus, Julien; Faletra, Francesco F.; Farmakis, Dimitrios; Filippatos, Gerasimos; Grapsa, Julia; Gustafsson, Finn; Hausleiter, Jörg; Jaarsma, Tiny; Karam, Nicole; Lund, Lars; Lurz, Philipp; Maisano, Francesco; Moura, Brenda; Mullens, Wilfred; Praz, Fabien; Sannino, Anna; Savarese, Gianluigi; Tocchetti, Carlo Gabriele; van Empel, Vanessa P.M.; von Bardeleben, Ralph Stephan; Yilmaz, Mehmet Birhan; Zamorano, José Luis; Ponikowski, Piotr; Barbato, Emanuele; Rosano, Giuseppe M.C.; Metra, Marco.
In: European Journal of Heart Failure, Vol. 26, No. 1, 2024, p. 18-33.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
AU - Adamo, Marianna
AU - Chioncel, Ovidiu
AU - Pagnesi, Matteo
AU - Bayes-Genis, Antoni
AU - Abdelhamid, Magdy
AU - Anker, Stefan D.
AU - Antohi, Elena Laura
AU - Badano, Luigi
AU - Ben Gal, Tuvia
AU - Böhm, Michael
AU - Delgado, Victoria
AU - Dreyfus, Julien
AU - Faletra, Francesco F.
AU - Farmakis, Dimitrios
AU - Filippatos, Gerasimos
AU - Grapsa, Julia
AU - Gustafsson, Finn
AU - Hausleiter, Jörg
AU - Jaarsma, Tiny
AU - Karam, Nicole
AU - Lund, Lars
AU - Lurz, Philipp
AU - Maisano, Francesco
AU - Moura, Brenda
AU - Mullens, Wilfred
AU - Praz, Fabien
AU - Sannino, Anna
AU - Savarese, Gianluigi
AU - Tocchetti, Carlo Gabriele
AU - van Empel, Vanessa P.M.
AU - von Bardeleben, Ralph Stephan
AU - Yilmaz, Mehmet Birhan
AU - Zamorano, José Luis
AU - Ponikowski, Piotr
AU - Barbato, Emanuele
AU - Rosano, Giuseppe M.C.
AU - Metra, Marco
N1 - Publisher Copyright: © 2023 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
PY - 2024
Y1 - 2024
N2 - Right-sided heart failure and tricuspid regurgitation are common and strongly associated with poor quality of life and an increased risk of heart failure hospitalizations and death. While medical therapy for right-sided heart failure is limited, treatment options for tricuspid regurgitation include surgery and, based on recent developments, several transcatheter interventions. However, the patients who might benefit from tricuspid valve interventions are yet unknown, as is the ideal time for these treatments given the paucity of clinical evidence. In this context, it is crucial to elucidate aetiology and pathophysiological mechanisms leading to right-sided heart failure and tricuspid regurgitation in order to recognize when tricuspid regurgitation is a mere bystander and when it can cause or contribute to heart failure progression. Notably, early identification of right heart failure and tricuspid regurgitation may be crucial and optimal management requires knowledge about the different mechanisms and causes, clinical course and presentation, as well as possible treatment options. The aim of this clinical consensus statement is to summarize current knowledge about epidemiology, pathophysiology and treatment of tricuspid regurgitation in right-sided heart failure providing practical suggestions for patient identification and management.
AB - Right-sided heart failure and tricuspid regurgitation are common and strongly associated with poor quality of life and an increased risk of heart failure hospitalizations and death. While medical therapy for right-sided heart failure is limited, treatment options for tricuspid regurgitation include surgery and, based on recent developments, several transcatheter interventions. However, the patients who might benefit from tricuspid valve interventions are yet unknown, as is the ideal time for these treatments given the paucity of clinical evidence. In this context, it is crucial to elucidate aetiology and pathophysiological mechanisms leading to right-sided heart failure and tricuspid regurgitation in order to recognize when tricuspid regurgitation is a mere bystander and when it can cause or contribute to heart failure progression. Notably, early identification of right heart failure and tricuspid regurgitation may be crucial and optimal management requires knowledge about the different mechanisms and causes, clinical course and presentation, as well as possible treatment options. The aim of this clinical consensus statement is to summarize current knowledge about epidemiology, pathophysiology and treatment of tricuspid regurgitation in right-sided heart failure providing practical suggestions for patient identification and management.
KW - Consensus statement
KW - Right heart failure
KW - Tricuspid regurgitation
U2 - 10.1002/ejhf.3106
DO - 10.1002/ejhf.3106
M3 - Journal article
C2 - 38131233
AN - SCOPUS:85182495299
VL - 26
SP - 18
EP - 33
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
SN - 1567-4215
IS - 1
ER -
ID: 383005031